Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Harms

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Occupational Health & Safety (Waco, Tex.)|April 12, 2007
Integrating safety into Kaizen eventsMichelle Harms
The Mental Health Clinician|March 8, 2019
Comparison of clozapine monitoring and adverse event management in a psychiatrist-only and a clinical pharmacist-psychiatrist collaborative clinicSamantha Maryan, Michelle Harms, Erin McAllister, et al.
The Mental Health Clinician|June 30, 2018
Impact of a mental health clinical pharmacist on a primary care mental health integration teamMichelle Harms, Matthew Haas, Janel Larew, et al.
The Mental Health Clinician|June 30, 2018
Overcoming barriers to monitoring patients taking second-generation antipsychoticsAnita Peña, Beth DeJongh, Matthew Haas, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Occupational Health & Safety (Waco, Tex.)|April 12, 2007
Integrating safety into Kaizen eventsMichelle Harms
The Mental Health Clinician|March 8, 2019
Comparison of clozapine monitoring and adverse event management in a psychiatrist-only and a clinical pharmacist-psychiatrist collaborative clinicSamantha Maryan, Michelle Harms, Erin McAllister, et al.
The Mental Health Clinician|June 30, 2018
Impact of a mental health clinical pharmacist on a primary care mental health integration teamMichelle Harms, Matthew Haas, Janel Larew, et al.
The Mental Health Clinician|June 30, 2018
Overcoming barriers to monitoring patients taking second-generation antipsychoticsAnita Peña, Beth DeJongh, Matthew Haas, et al.
Pageof 1